Pamecha Viniyendra, Sasturkar Shridhar Vasantrao, Sinha Piyush Kumar, Mahansaria Shyam Sundar, Bharathy Kishore G S, Kumar Senthil, Rastogi Archana
Department of Liver Transplantation and Hepato-Pancreato-Biliary Surgery, Institute of Liver and Biliary Sciences, New Delhi, Delhi India.
Department of Pathology, Institute of Liver and Biliary Sciences, New Delhi, Delhi India.
Indian J Surg. 2017 Aug;79(4):326-331. doi: 10.1007/s12262-016-1545-3. Epub 2016 Sep 3.
Optimal management of large and locally advanced hepatocellular carcinoma (HCC) remains a clinical challenge especially in patients with chronic liver disease (CLD). We present our experience of major liver resection for large and locally advanced HCC. Prospectively collected data of patients with large and locally advanced HCC who underwent major liver resection between March 2011 and May 2015. The outcome measures of interest were the characteristics of tumor, surgical outcome, and overall as well as disease-free survival. Eighteen patients (14 male) with median age of 59 years (20 to 73 years) with good performance status underwent resection. Fifteen patients were in Child Pugh class A and three in class B. On contrast-enhanced computed tomography (CECT) scan, four patients had lobar/segmental portal vein involvement, two patients had bilobar disease, and one had biliary obstruction. Seven patients underwent extended resection (>5 segments), five right hepatectomy, two modified right hepatectomy, one modified right hepatectomy with wedge resection of segment six, two left hepatectomy, and one left lateral sectionectomy. On histopathology, 12 were solitary and six were multiple, the median tumor diameter was 9 cm (5-18 cm). All 18 patients had R0 resection. Eight patients had cirrhosis, six had fibrosis, and four had chronic hepatitis. Vascular invasion was noticed in 12 and out of these, six had large-vessel embolization. Morbidity according to Clavien-Dindo class was grades 1-11, grades 2-5, grade 3B-1, and grades 5-1. After a median follow-up of 32 months (6-54 months), the overall survival at 1 and 3 years was 83 and 54 %, respectively. The disease-free survival at 1 and 3 years was 75 and 54 % respectively. In carefully selected patients with large and locally advanced HCC, acceptable perioperative and medium term outcomes can be achieved with major liver resection.
对于大肝癌和局部晚期肝癌(HCC)的最佳治疗仍是一项临床挑战,尤其对于患有慢性肝病(CLD)的患者。我们展示了我们对大肝癌和局部晚期肝癌进行肝大部切除术的经验。前瞻性收集了2011年3月至2015年5月期间接受肝大部切除术的大肝癌和局部晚期肝癌患者的数据。感兴趣的结局指标包括肿瘤特征、手术结果以及总生存率和无病生存率。18例患者(14例男性)接受了手术,中位年龄59岁(20至73岁),身体状况良好。15例患者为Child Pugh A级,3例为B级。在对比增强计算机断层扫描(CECT)上,4例患者有叶/段门静脉受累,2例患者为双叶病变,1例有胆道梗阻。7例患者接受了扩大切除术(>5个肝段),5例接受了右半肝切除术,2例接受了改良右半肝切除术,1例接受了改良右半肝切除术并楔形切除第6肝段,2例接受了左半肝切除术,1例接受了左外叶切除术。组织病理学检查显示,12例为单发,6例为多发,中位肿瘤直径为9 cm(5至18 cm)。所有18例患者均实现R0切除。8例患者有肝硬化,6例有肝纤维化,4例有慢性肝炎。12例患者出现血管侵犯,其中6例接受了大血管栓塞。根据Clavien-Dindo分级,术后并发症分级为1-11级2例、2-5级5例、3B-1级1例、5-1级1例。中位随访32个月(6至54个月)后,1年和3年总生存率分别为83%和54%。1年和3年无病生存率分别为75%和54%。对于精心挑选的大肝癌和局部晚期肝癌患者,肝大部切除术可实现可接受的围手术期和中期结局。